AA

DRUG3 trials

Sponsors

Radiation Therapy Oncology Group, Cedars-Sinai Medical Center

Conditions

Coronary Artery DiseaseMenopauseProstate Cancer

Phase 3

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Active, not recruitingNCT00567580

Radiation Therapy Oncology GroupProstate Cancer

Start: 2008-02-29Updated: 2025-05-09

Unknown Phase

The Effects of Traditional Acupuncture on Mechanisms of Coronary Heart Disease

CompletedNCT00570024

Cedars-Sinai Medical CenterCoronary Artery Disease

Start: 2006-01-31End: 2010-03-31Updated: 2019-04-10

Pilot Study - Impact of Traditional Acupuncture on Menopause

CompletedNCT00950482

Cedars-Sinai Medical CenterMenopause

Start: 2009-01-31End: 2010-02-28Updated: 2019-04-10

Related Papers

Decipher score as a predictor of response to treatment intensification in the NRG Oncology-RTOG 0534 (SPPORT) phase III randomized post-prostatectomy salvage radiotherapy trial.

Journal of Clinical Oncology2025-02-103 citations

Neurocognitive function outcomes in NRG/RTOG 0534, the SPPORT trial.

Journal of Clinical Oncology2023-06-01

The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.

2022-05-01162 citations